Hepatitis C virus (HCV) infection is the major risk factor for liver cirrhosis and hepatocellular
carcinoma (HCC). The mechanisms of HCC initiation, growth, and metastasis appear to be …

Immunity to viruses - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI
Homepage MyNCBI Homepage Main Content Main Navigation Preview improvements coming …

Background. Chronic hepatitis C virus (HCV) infection is a global health problem, resulting
in liver failure, hepatocellular carcinoma, and liver-related death. Natural killer (NK) cells are …

This review focuses on research findings in the area of diagnosis and pathogenesis of
hepatitis C virus (HCV) infection over the last few decades. The information based on …

Recently, the treatment of HCV has advanced significantly due to the introduction of direct‐
acting antivirals (DAA s). Studies using interferon (IFN)‐containing regimens failed to …

The majority of individuals who become acutely infected with hepatitis C virus (HCV)
develop chronic infection and suffer from progressive liver damage while approximately …

The hepatitis C virus (HCV) infects∼ 200 million people worldwide. The majority of infected
individuals develop persistent infection, resulting in chronic inflammation and liver disease …

Hepatitis C virus (HCV) remains a public health problem of global importance, even in the
era of potent directly-acting antiviral drugs. In this chapter, I discuss immune responses to …

Natural killer (NK) cells are key players in the immune system. They use receptors on their
cell surface to identify target cells. However, to escape being killed by the immune system …

Patients infected with the hepatitis C virus (HCV) are characterized by a high incidence of
chronic infection, which results in chronic hepatitis, liver cirrhosis, and hepatocellular …